Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pathological complete response (pCR) rate in
breast cancer patients treated with weekly paclitaxel plus carboplatin preoperative regimen.